MNEXSPIKE Interactions
There are 352 drugs known to interact with mNEXSPIKE (COVID-19 mRNA (Moderna) vaccine), along with 3 disease interactions. Of the total drug interactions, 1 is major, 348 are moderate, and 3 are minor.
- View all 352 medications that may interact with mNEXSPIKE
- View mNEXSPIKE disease interactions (3)
Most frequently checked interactions
View interaction reports for mNEXSPIKE (COVID-19 mRNA (Moderna) vaccine) and the medicines listed below.
- Abrysvo (rsv vaccine, pref a-pref b, recombinant)
- acetaminophen
- acyclovir topical
- Adacel (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- Adderall (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- albuterol
- albuterol / ipratropium
- alfuzosin
- Allegra (fexofenadine)
- Allegra-D 12 Hour (fexofenadine / pseudoephedrine)
- Allegra-D 24 Hour Allergy & Congestion (fexofenadine / pseudoephedrine)
- amoxicillin
- Azithromycin Dose Pack (azithromycin)
- Celebrex (celecoxib)
- Eliquis (apixaban)
- famotidine
- fexofenadine
- Fluzone High-Dose Quadrivalent (influenza virus vaccine, inactivated)
- Gaviscon Extra Strength (aluminum hydroxide / magnesium carbonate)
- influenza virus vaccine, inactivated
- Lidoderm (lidocaine topical)
- metaxalone
- Metoprolol Succinate ER (metoprolol)
- molnupiravir
- Paxlovid (nirmatrelvir / ritonavir)
- PreserVision AREDS 2 (multivitamin with minerals)
- tramadol
- Xalatan (latanoprost ophthalmic)
- Zostavax (zoster vaccine live)
MNEXSPIKE disease interactions
There are 3 disease interactions with mNEXSPIKE (COVID-19 mRNA (Moderna) vaccine) which include:
More about mNEXSPIKE (COVID-19 mRNA (Moderna) vaccine)
- mNEXSPIKE consumer information
- Compare alternatives
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.